DK149429C - Analogifremgangsmaade til fremstilling af thiazolidin-2,4-dionderivater eller syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af thiazolidin-2,4-dionderivater eller syreadditionssalte deraf

Info

Publication number
DK149429C
DK149429C DK582578A DK582578A DK149429C DK 149429 C DK149429 C DK 149429C DK 582578 A DK582578 A DK 582578A DK 582578 A DK582578 A DK 582578A DK 149429 C DK149429 C DK 149429C
Authority
DK
Denmark
Prior art keywords
thiazolidine
analogue
preparation
acid addition
addition salts
Prior art date
Application number
DK582578A
Other languages
Danish (da)
English (en)
Other versions
DK582578A (da
DK149429B (da
Inventor
Dennis Claude Bigg
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7739559A external-priority patent/FR2413381A1/fr
Priority claimed from FR7833244A external-priority patent/FR2442232A2/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of DK582578A publication Critical patent/DK582578A/da
Publication of DK149429B publication Critical patent/DK149429B/da
Application granted granted Critical
Publication of DK149429C publication Critical patent/DK149429C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
DK582578A 1977-12-29 1978-12-27 Analogifremgangsmaade til fremstilling af thiazolidin-2,4-dionderivater eller syreadditionssalte deraf DK149429C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR7739559A FR2413381A1 (fr) 1977-12-29 1977-12-29 Derives de thiazolidinedione et leur application en therapeutique
FR7739559 1977-12-29
FR7833244 1978-11-24
FR7833244A FR2442232A2 (fr) 1978-11-24 1978-11-24 Derives de thiazolidinedione-2,4 et leur application en therapeutique

Publications (3)

Publication Number Publication Date
DK582578A DK582578A (da) 1979-06-30
DK149429B DK149429B (da) 1986-06-09
DK149429C true DK149429C (da) 1987-03-09

Family

ID=26220372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK582578A DK149429C (da) 1977-12-29 1978-12-27 Analogifremgangsmaade til fremstilling af thiazolidin-2,4-dionderivater eller syreadditionssalte deraf

Country Status (17)

Country Link
US (1) US4349683A (no)
EP (1) EP0002978B1 (no)
JP (1) JPS6011908B2 (no)
AR (1) AR223160A1 (no)
AT (1) AT370098B (no)
AU (1) AU517221B2 (no)
CA (1) CA1107740A (no)
DE (1) DE2862059D1 (no)
DK (1) DK149429C (no)
ES (1) ES476408A1 (no)
FI (1) FI68819C (no)
GR (1) GR65312B (no)
IE (1) IE47902B1 (no)
IL (1) IL56304A (no)
NO (1) NO148454C (no)
NZ (1) NZ189300A (no)
PT (1) PT68991A (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6610081A (en) * 1980-01-24 1981-07-30 Senju Pharmaceutical Co., Ltd. Thiazolidine derivatives
JPH0750560B2 (ja) * 1981-05-09 1995-05-31 ヤマハ株式会社 ディジタル集積回路装置
US4456756A (en) * 1981-08-03 1984-06-26 Mead Johnson & Company Spirothiazolidinyl piperazine derivatives
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
DE69214467T3 (de) * 1991-01-10 2000-09-28 Transcend Therapeutics Inc Verwendung von L-2-oxo Thiazolidin-4-carboxylat zur Behandlung von Atemnotsyndrom
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
KR20150068829A (ko) * 2013-12-12 2015-06-22 삼성전자주식회사 알킬 암모늄염 화합물을 포함하는 유도 용질

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1435004A (fr) * 1965-02-04 1966-04-15 Sobio Lab Dérivés de thiazolidine-dione-2, 4- et procédé de préparation

Also Published As

Publication number Publication date
CA1107740A (en) 1981-08-25
EP0002978A2 (fr) 1979-07-11
FI68819C (fi) 1985-11-11
FI68819B (fi) 1985-07-31
AR223160A1 (es) 1981-07-31
ATA936678A (de) 1982-07-15
NZ189300A (en) 1980-05-27
DK582578A (da) 1979-06-30
IL56304A (en) 1982-02-28
FI783995A (fi) 1979-06-30
DK149429B (da) 1986-06-09
AT370098B (de) 1983-02-25
ES476408A1 (es) 1979-04-01
IE782561L (en) 1979-06-29
JPS5498758A (en) 1979-08-03
EP0002978B1 (fr) 1982-10-06
DE2862059D1 (en) 1982-11-11
PT68991A (fr) 1979-01-01
AU4296178A (en) 1979-07-05
EP0002978A3 (en) 1979-07-25
IL56304A0 (en) 1979-03-12
NO148454C (no) 1983-10-12
GR65312B (en) 1980-08-02
NO148454B (no) 1983-07-04
JPS6011908B2 (ja) 1985-03-28
US4349683A (en) 1982-09-14
IE47902B1 (en) 1984-07-25
AU517221B2 (en) 1981-07-16
NO784382L (no) 1979-07-02

Similar Documents

Publication Publication Date Title
DK150512C (da) Analogifremgangsmaade til fremstilling af 3-quino-lincarboxylsyrederivater eller syreadditionssalte deraf
DK149111C (da) Analogifremgangsmaade til fremstilling af histidinderivater eller syreadditionssalte deraf
DK144010C (da) Analogifremgangsmaade til fremstilling af 2-piperazinyl-6,7-dimethoxyquinazoliner eller syreadditionssalte deraf
DK163244C (da) Analogifremgangsmaade til fremstilling af 7-oe2-(2-aminothiazol-4-yl)-2-oxyimino-acetamidoaa-ceph-3-em-4-carboxylsyrederivater eller fysiologisk acceptable salte deraf
DK462380A (da) Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller syreadditionssalte deraf
DK149850C (da) Analogifremgangsmaade til fremstilling af 5-(3,4-disubst. phenyl)-oxazolidinoner eller thiazolidinoner eller de tilsvarende thioner
DK151623C (da) Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK147362C (da) Analogifremgangsmaade til fremstilling af ergolen- eller ergolin-derivater eller syreadditionssalte deraf
DK149594C (da) Analogifremgangsmaade til fremstilling af dipeptidderivater eller syreadditionssalte heraf
DK145260C (da) Analogifremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer eller syreadditionssalte heraf
DK148477C (da) Analogifremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf
DK258078A (da) Fremgangsmaade til fremstilling af 7alfa-methoxy-7beta-(1,3-dithiethan-2-carboxamido) cephalosporansyre-derivater
DK147858C (da) Analogifremgangsmaade til fremstilling af 5'-deoxy-5-fluorcytidin eller 5'-deoxy-5-fluoruridin eller fysiologisk tolerable syreadditionssalte dera
DK146592C (da) Analogifremgangsmaade til fremstilling af n-substituerede benzensulfonamider eller syreadditionssalte deraf
DK149429C (da) Analogifremgangsmaade til fremstilling af thiazolidin-2,4-dionderivater eller syreadditionssalte deraf
DK533979A (da) Fremgangsmaade til fremstilling af thiazolylderivater
DK146281C (da) Analogifremgangsmaade til fremstilling af 2-brom-6-fluor-n-2-imidazolidinyliden-benzamin eller syreadditionssalte heraf
DK151805C (da) Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf
DK149841C (da) Analogifremgangsmaade til fremstilling af alfa-fluor-methyl-alfa-aminoalkansyrer eller farmaceutisk acceptable syreadditionssalte deraf
DK148281C (da) Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf
DK149628C (da) Analogifremgangsmaade til fremstilling af 8-substitueret-4ae-amino-makrolider eller syreadditionssalte deraf
DK151629C (da) Analogifremgangsmaade til fremstilling af 3-amino-1-benzoxepin-5(2h)-on-derivater eller syreadditionssalte deraf
DK152754C (da) Analogifremgangsmaade til fremstilling af 1-acyl-8-(3-amino-2-hydroxypropoxy)-1,2,3,4-tetrahydroquinoliner eller farmaceutisk acceptable syreadditionssalte deraf
DK148036C (da) Analogifremgangsmaade til fremstilling af epimere 4''-amino-erythromycin-forbindelser eller syreadditionssalte deraf
DK148683C (da) Analogifremgangsmaade til fremstilling af pyridazinylhydrazinderivater eller farmaceutisk acceptable syreadditionssalte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed